NeuPath Health Inc
XTSX:NPTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NeuPath Health Inc
XTSX:NPTH
|
CA |
|
Intracom Holdings SA
F:INTA
|
GR |
Intrinsic Value
The intrinsic value of NeuPath Health Inc (NPTH) under the Base Case is 1.68 CAD per share.
Compared with the current market price of 0.56 CAD, the stock appears
Undervalued by 67% .
The intrinsic value is calculated using the DCF method. Net margin recovers from roughly break-even last year to 5.8% by 2036. If net margin stayed at its five-year average of -2.8%, the estimate would be about CA$0.37. The value of the years after 2036 is tied to revenue, so margins count only until then.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What NeuPath Health Does
NeuPath Health Inc. is a Canadian healthcare services company focused on diagnosing and treating chronic pain and related neurological conditions. It runs specialist clinics where patients can see doctors, get assessments, and receive treatment plans for issues such as back pain, nerve pain, headaches, and other disorders that often need long-term management.
- Headquarters
- Canada CA
- Employees
- 152
- IPO date
- Dec 3, 2019
Earnings Waterfall
NeuPath Health Inc
The intrinsic value for NeuPath Health Inc (NPTH) under the Base Case is 1.68 CAD.
Compared with the current market price of 0.56 CAD, the stock appears Undervalued by 67% .